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Acute Inhibition of Excessive Mitochondrial Fission After Myocardial
Infarction Prevents Long-term Cardiac Dysfunction
Marie-Helene Disatnik, PhD;* Julio C.B. Ferreira, PhD;* Juliane Cruz Campos, MSc; Katia Sampaio Gomes, BSc;
Paulo M.M. Dourado, MD, PhD; Xin Qi, PhD; Daria Mochly-Rosen, PhD
Background-—Ischemia and reperfusion (IR) injury remains a major cause of morbidity and mortality and multiple molecular and
cellular pathways have been implicated in this injury. We determined whether acute inhibition of excessive mitochondrial ﬁssion at
the onset of reperfusion improves mitochondrial dysfunction and cardiac contractility postmyocardial infarction in rats.
Methods and Results-—We used a selective inhibitor of the ﬁssion machinery, P110, which we have recently designed. P110
treatment inhibited the interaction of ﬁssion proteins Fis1/Drp1, decreased mitochondrial ﬁssion, and improved bioenergetics in
three different rat models of IR, including primary cardiomyocytes, ex vivo heart model, and an in vivo myocardial infarction model.
Drp1 transiently bound to the mitochondria following IR injury and P110 treatment blocked this Drp1 mitochondrial association.
Compared with control treatment, P110 (1 lmol/L) decreased infarct size by 282% and increased adenosine triphosphate levels
by 70+1% after IR relative to control IR in the ex vivo model. Intraperitoneal injection of P110 (0.5 mg/kg) at the onset of
reperfusion in an in vivo model resulted in improved mitochondrial oxygen consumption by 68% when measured 3 weeks after
ischemic injury, improved cardiac fractional shortening by 35%, reduced mitochondrial H2O2 uncoupling state by 70%, and
improved overall mitochondrial functions.
Conclusions-—Together, we show that excessive mitochondrial ﬁssion at reperfusion contributes to long-term cardiac dysfunction
in rats and that acute inhibition of excessive mitochondrial ﬁssion at the onset of reperfusion is sufﬁcient to result in long-term
beneﬁts as evidenced by inhibiting cardiac dysfunction 3 weeks after acute myocardial infarction. ( J Am Heart Assoc. 2013;2:
e000461 doi: 10.1161/JAHA.113.000461)
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T he ﬁrst observation that cardiac mitochondria changetheir size and number through ﬁssion and fusion was
made more than 4 decades ago,1 and the key role of
mitochondrial dysfunction in ischemia and reperfusion (IR)
injury and cardiomyopathy has been subsequently recog-
nized.2–4 Mitochondrial ﬁssion is required to eliminate
damaged or aged mitochondria via autophagy.5 However,
excessive mitochondrial ﬁssion can contribute to ischemia/
reperfusion injury and to heart failure.6,7 Therefore, inhibition
of excessive mitochondrial ﬁssion might be crucial to maintain
proper mitochondrial function and cardiac function.
In yeast, ﬁssion is controlled by the translocation of
cytosolic Dnm1 (yeast dynamin-related protein 1; drp1) and
its interaction with the outer mitochondrial protein, ﬁssion
protein 1 (Fis1).8,9 In addition to Fis1, other adaptor proteins,
mitochondrial ﬁssion factor (Mff)10 and mitochondrial elon-
gation factor 1(MIEF1 [MiD51])11,12 at the surface of
mitochondria in mammals, bind dynamin related protein 1
(Drp1) to promote ﬁssion or fusion respectively. A study in
HL-1 cells showed that inhibiting mitochondrial ﬁssion
reduces IR injury. Two hours of ischemia induced mitochon-
drial fragmentation that persisted during the 5 hours of
reperfusion.13 Fragmentation of mitochondria was inhibited
by pretreatment with a pharmacological inhibitor of Drp1,
mitochondrial division inhibitor (mdivi-1)14 (given prior to the
ischemic event), suggesting that this excessive mitochondrial
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ﬁssion and fragmentation is dependent on Drp1.15 Mitochon-
drial fragmentation was also observed in mouse hearts after
coronary artery occlusion followed by reperfusion. Under
these conditions, treatment with mdivi-1 before the ischemic
period reduced infarct size in vivo when measured 2 hours
after myocardial infarction (MI).15 These reports provide
evidence that inhibiting the mitochondrial ﬁssion machinery
prior to ischemic insult protects the heart against ischemia
and reperfusion injury.
Although myocardial ischemia per se causes tissue dam-
age due to increased acidity, sodium, and calcium overload,
and to adenosine triphosphate (ATP) depletion, the return of
blood ﬂow, termed reperfusion, aggravates these injurious
effects due to increased reactive oxygen species (ROS) levels
and uncoupling of mitochondrial oxidative phosphoryla-
tion.16,17 Here, we set out to determine whether inhibition
of mitochondrial fragmentation can produce beneﬁt when
given after MI and the consequence of acute inhibition of
mitochondrial fragmentation on long-term cardiac functions.
We made use of Drp1 inhibitor, P110, a peptide that we
recently rationally designed to selectively inhibit Fis1/Drp1
interaction.18 This 7-amino-acid peptide represents a homol-
ogous sequence between Fis1 and Drp1. We demonstrated
that P110 does not affect Drp1 interaction with the two other
mitochondrial adaptors of Drp1, Mff, and MIEF1(MiD51), or
with the mitochondrial fusion proteins, Mfn1 or Mfn2.18 In a
model of Parkinson’s disease in culture, we also showed that
inhibiting Drp1/Fis1 interaction reduced excessive mitochon-
drial fragmentation and ROS production as well as improved
mitochondrial membrane potential and mitochondrial integ-
rity.18 In the current study, we used P110 peptide to
determine the role of Drp1/Fis1 interaction in reperfusion-
induced injury using primary rat cultured cardiac myocytes, an
ex vivo rat heart model, and an in vivo rat model of myocardial
infarction. We determined also the long-term consequences of
acute inhibition of Drp1 after the ischemic event on devel-
opment of post-MI cardiac dysfunction.
Methods
Peptide Synthesis
Peptides were synthesized using microwave chemistry on a
Liberty Microwave Peptide Synthesizer (CEM Corporation) as
previously described.18 Brieﬂy, peptides were synthesized
as one polypeptide with TAT47-57 carrier in the following order:
N-terminus–TAT–spacer (Gly-Gly)–cargo–C-terminus.
Cell Culture
Primary cultures of cardiac myocytes were prepared from
the heart of 1-day-old rats by gentle digestion at 37°C
using a cell isolation kit protocol (Cellutron). Cells were
cultured in the presence of 0.1 mmol/L bromodeoxyuridine
on primary tissue culture dishes (BD Falcon) or on laminin-
coated slides in Dulbeco’s modiﬁed Eagle’s medium with
10% fetal bovine serum for 4 days. The cells were washed
with PBS and incubated at 37°C for 2 hours in ischemia
buffer (NaCl 125 mmol/L, KCl 8 mmol/L, KH2PO4
1.2 mmol/L, MgSO4 1.25 mmol/L, CaCl2 1.2 mmol/L,
NaHCO3 6.25 mmol/L, sodium lactate 5 mmol/L, Hepes
20 mmol/L, pH 6.6) in a GasPak pouch (Becton Dickinson).
Then the cells were reexposed to oxygen and the buffer
was replaced by reoxygenation Krebs-Henseleit buffer (NaCl
110 mmol/L, KCl 4.7 mmol/L, KH2PO4 1.2 mmol/L,
MgSO4 1.25 mmol/L, CaCl2 1.2 mmol/L, NaHCO3
25 mmol/L, glucose 15 mmol/L, Hepes 20 mmol/L, pH
7.4) for the indicated time. Treatments with control
peptide (TAT47-57) or P110 commenced 30 minutes before
ischemia and continued during ischemia and reoxygenation
(1 lmol/L).
Isolation of Mitochondrial-enriched Fraction and
Lysate Preparation
Cardiac myocyte cells were washed with cold PBS and
incubated on ice in lysis buffer (300 mmol/L sucrose,
10 mmol/L Hepes, 2 mmol/L EDTA, pH 7.2) for 30
minutes in the presence of protease inhibitor cocktail and
phosphatase inhibitor cocktail. Cells were scraped and then
disrupted 10 times by repeated aspiration through a
27-gauge needle. The homogenates were spun at 800g
for 5 minutes at 4°C and the resulting supernatants were
spun at 10 000g for 20 minutes at 4°C. The pellets were
washed with lysis buffer and spun at 10 000g again for
20 minutes at 4°C. The ﬁnal pellets were suspended in lysis
buffer containing 1% Triton X-100 and were noted as
mitochondrial-rich lysate fractions. The mitochondrial mem-
brane protein voltage-dependent anion channel (VDAC) was
used as marker and loading control for mitochondrial
fractions and enolase was used as a marker and loading
control for total fractions.
Co-immunoprecipitation
Coimmunoprecipitation experiments were performed as
already described.18,19 Brieﬂy, proteins from cardiac myo-
cytes were cross-linked in 1% paraformaldehyde followed by
washing in PBS containing 100 mmol/L glycine. The cells
were then lysed by sonication in PBS with 1% Triton X-100
and incubated with the respective antibodies and protein
A/G agarose. The immunoprecipitates were loaded on a
SDS-PAGE and probed with Drp1 antibody, as described
above.
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Immunocytochemistry
Cells cultured on chamber slides were treated with respective
peptides as above and subjected to ischemia and reoxygen-
ation (IRO). At the end of the incubation the cells were
washed with cold PBS, ﬁxed in 4% formaldehyde then blocked
for 2 hours with 2% normal goat serum in PBS containing
0.1% Triton-X (blocking buffer). The cells were then incubated
overnight at 4°C with antibodies against Tom-20 (Santa Cruz
Biotechnology, 1:500). Cells were washed with blocking buffer
and incubated for 2 hours with Alexa546-labeled goat anti-
rabbit antibody (1:500, Invitrogen). Slides were mounted and
imaged by Leica SP5 multiphoton/confocal Laser Scanning
Microscope using a 963 oil immersion objective. To deter-
mine superoxide production in cultures, cells plated on
laminin-coated 96 well plates were incubated after 2 hours
of ischemia and 3 hours of reoxygenation with 5 lmol/L
CellRox for 45 minutes or MitoSOX red mitochondrial super-
oxide indicator (Invitrogen) for 10 minutes at 37°C. Staining
was carried out in presence of DAPI to enable counting cell
numbers. The level of ﬂuorescence staining was analyzed
using a ﬂuorescent plate reader (High-Throughput Bioscience
Center, Stanford) at 640 nm excitation and 665 nm emission
or 510 nm excitation and 590 nm emission, for CellRox and
MitoSOX, respectively and normalized to DAPI staining level.
Ex vivo Model of Cardiac Ischemia-reperfusion
All protocols were approved by the Stanford University
Institutional Animal Care and Use Committee. Male Wistar
rats (270–300 g) were heparinized (1000 U/kg IP) and then
anesthetized with Beuthanasia-D, (pentobarbital sodium
6240 mg/kg and phenytoin sodium 800 mg/kg IP) (Scher-
ing-Plough Animal Health Crop). Then, the hearts were
perfused via the aorta at 10 mL/min with oxygenated
Krebs–Henseleit buffer containing NaCl (120 mmol/L), KCl
(5.8 mmol/L), NaHCO3 (25 mmol/L), NaH2PO4 (1.2 mmol/L),
MgSO4 (1.2 mmol/L), CaCl2 (1 mmol/L), and dextrose
(10 mmol/L) at pH 7.4 in a Langendorff coronary perfusion
system at 37°C. The hearts were subjected to 30 minutes
global, no-ﬂow ischemia followed by 90 minutes of reperfu-
sion. TAT47-57 (control peptide) and P110 peptide (1 lmol/L)
were perfused during the entire equilibration and reperfusion
period (Figure 3A). Normoxic control hearts were subjected to
120 minutes perfusion in the absence of ischemia. At the end
of the reperfusion period, hearts were sliced into 1-mm-thick
transverse sections and incubated in triphenyltetrazolium
chloride solution (TTC, 1% in phosphate buffer, pH 7.4) at
37 °C for 15 minutes then ﬁxed in 10% formalin. Infarct size
was expressed as a percentage of the risk zone (equivalent to
total LV muscle mass) as we previously described.20 We used
6 animals per group (control and treated-group).
Measurement of Cardiac ATP Levels
ATP levels were measured in total extract samples from heart
after ex vivo IR injury using ATP determination kit protocol
(Invitrogen). Brieﬂy, 100 to 150 mg cross sections of heart
tissue were weighed then lysed in 1% TCA after the weight of
each section was determined for further normalization. The
tissue debris was spun down and the supernatants were
brought to pH 7. Ten lL of each lysate was used in the assay
in a total volume of 200 lL reaction buffer. The level of ATP
was measured using a luminometer plate reader and the
amount was normalized to the wet tissue weight (nmol/mg).
Electron Microscopy of Heart Ex vivo
Thin sections of respective heart tissue after IR were ﬁxed in
2.5% glutaraldehyde in 0.1 mol/L cacodylate buffer, pH=7.4.
The ﬁxed material was sectioned at the Stanford Electron
Microscopy Facility. Sections were taken between 75 and
80 nm, picked up on formvar/Carbon coated 75 mesh Ni
grids and stained for 20 seconds in 1:1 saturated uracetate
(7.7%) in acetone followed by staining in 0.2% lead citrate
for 3 to 4 minutes for contrast. Mitochondrial samples were
observed in a JEOL 1230 transmission electron microscope at
80 kV and photos were taken using a Gatan Multiscan 791
digital camera.
In vivo Rat Acute Myocardial Infarction Model
Acute myocardial infarction (AMI) was induced by ligation of
the left anterior descending (LAD) coronary artery for
30 minutes, as previously described.20–22 Male Wistar rats
were anesthetized with ketamine (50 mg/kg IP) and xylazine
(10 mg/kg IP), endotracheally intubated, and mechanically
ventilated with room air (respiratory rate of 80 breaths/min
and tidal volume of 2.5 mL). Body temperature was main-
tained at 37°C using a rectal probe linked to a thermocoupled
thermometer and an appropriate heating blanket. The heart
was exposed by a left thoracotomy between the fourth and
ﬁfth ribs. After a 10-minute period of stabilization, the LAD
coronary artery was ligated close to its origin from the aortic
root. The normoxia control animals (sham) were exposed to
the same procedure with no ligation. The free ends of the
ligature were used to form a noose around a syringe plunger
which was placed ﬂat on the myocardium. Coronary occlusion
was achieved by tightening the noose around the plunger for
30 minutes. Occlusion was determined by observation of
immediate pallor of the LV free wall and reﬂow was achieved
by release of the ligature just after injecting an intraperitoneal
injection (IP) 0.5 mg/kg of the respective peptides. A 4-0
vicryl absorbance suture was used to close the chest and a
nylon suture to stitch the skin. Buprenorphine (0.05 mg/kg)
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was given subcutaneously every 8 hours for 2 days postop-
eratively. Fractional shortening was determined in 6 to 7 rats
per group at 3 days and 3 weeks after MI by M-mode
echocardiography.
Echocardiographic Measurements
Noninvasive cardiac function was assessed by two-dimen-
sional (2D)–guided M-mode echocardiography in 1% vaporized
isoﬂurane-anesthetized rats after the experimental period as
described previously.22 Transthoracic echocardiography was
performed using an Acuson Sequoia model 512 echocardiog-
rapher equipped with a 14-MHz linear transducer. LV systolic
function was estimated by fractional shortening (FS) as
follows: FS (%)=[(LVEDD–LVESD)/LVEDD]9100, where
LVEDD is the LV end-diastolic diameter, and LVESD is the
LV end-systolic diameter. For the data shown in Table, 2D
parasternal short-axis views of the LV were obtained at the
level of the papillary muscles. M-mode tracings were obtained
from the short-axis views of the LV at or just below the tip of
the mitral-valve leaﬂets and at the level of the aortic valve and
left atrium. All LV structures were manually measured by the
same blinded observer, using the leading-edge method of the
American Society of Echocardiography that has been vali-
dated for the infarcted rat model. The measurements obtained
were the mean of at least 5 cardiac cycles on the M-mode
tracings. All echocardiographic evaluations were performed by
the same examiner who was blinded to the experimental
conditions. The number of animals used for the analyses is
mentioned at the top of each respective group in the table.
Mitochondrial Isolation
Heart mitochondria were isolated as described elsewhere23
from 6 rats per group. Brieﬂy, cardiac samples from a remote
area were minced and homogenized in isolation buffer
(300 mmol/L sucrose, 10 mmol/L Hepes, 2 mmol/L EGTA,
pH 7.2, 4°C) containing 0.1 mg/mL of type I protease (bovine
pancreas) to release mitochondria from within muscle ﬁbers
and later washed in the same buffer in the presence of 1 mg/mL
bovine serum albumin. The suspension was homogenized in a
40-mL tissue grinder and centrifuged at 950g for 5 minutes.
The resulting supernatant was centrifuged at 9500g for
10 minutes. The mitochondrial pellet was washed, resus-
pended in isolation buffer and centrifuged again (9500g for
10 minutes). The mitochondrial pellet was washed and the
ﬁnal pellet was resuspended in a minimal volume of isolation
buffer. The respective fractions were analyzed by Western blot
using antibodies against Drp1 (BD), microtubule-associated
protein 1 light chain 3 (LC3-II) (Cell Signaling), Jun kinase
(JNK), and p-JNK (Cell Signaling). The distinct cellular fractions
were identiﬁed by their respective loading control; VDAC
(MitoSciences), was used to identify mitochondria and
enolase (Santa Cruz Biotechnology) for total fraction.
Analysis of Mitochondrial Size
Flow cytometric analysis of mitochondrial size was deter-
mined in isolated cardiac mitochondria.24 The mitochondria
were stained with 400 nmol/L MitoTraker Red CMXRos
(Invitrogen) for 15 minutes at 37°C then ﬁxed in 4%
formaldehyde for 15 minutes in warmed 5% sucrose in PBS
to avoid ﬁssion25 before analyzing mitochondrial size. Mito-
chondria size was measured by recording forward scatter
measurement using R-Phycoerythrin (PE) channel on LSRII BD
ﬂow cytometer.
Mitochondrial O2 Consumption
Mitochondrial O2 consumption was monitored in a 0.125 mg
mitochondrial protein/mL suspension in a buffer containing
125 mmol/L sucrose, 65 mmol/L KCl, 10 mol/L Hepes, 2
mmol/L inorganic phosphate, 2 mmol/L MgCl2, 100 lmol/L
EGTA and 0.01% bovine serum albumin, pH 7.2 using a
computer-interfaced Clark-type electrode (OROBOROS Oxy-
graph-2k) operating with continuous stirring at 37°C.23 Suc-
cinate, malate and glutamate (2 mmol/L of each) were used as
substrates and adenosine diphosphate (ADP) (1 mmol/L) was
added to induce state-3 respiratory rate. A subsequent addition
of oligomycin (1 lg/mL) was used to determine state-4 rate.
RCR by dividing state-3 by state-4 oxygen consumption rates,
which demonstrates the tightness of the coupling between
mitochondrial respiration and phosphorylation was calculated.
Mitochondrial H2O2 Release
Mitochondrial H2O2 release was measured, as described
elsewhere,23 in 0.125 mg protein/mL mitochondrial suspen-
sions in buffer under the same conditions as oxygen
consumption measurements. Amplex Red (25 lmol/L) oxida-
tion was followed in the presence of 0.5 U/mL horseradish
peroxidase and using succinate, malate, and glutamate
(2 mmol/L of each) as substrates. Amplex Red is oxidized
in the presence of extramitochondrial horseradish peroxidase
bound to H2O2, generating resoruﬁn, which can be detected
using a ﬂuorescence spectrophotometer. Excitation/emission
wavelengths were 563/587 nm. Calibration was conducted
by adding known amounts of H2O2 (A240=43.6
(mol L1)1 cm1) to the experimental buffer.
Statistical Analysis
Data are presented as meansstandard error of the mean
(SEM). One-way analysis of variance (ANOVA) was used to
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analyze the data shown in Figures 2A, 2B, 3D, 3E, 4B through
4F, and 5. Two-way ANOVA was used to analyze data depicted
in Table and Figures 2C and 6. Whenever signiﬁcant F-values
were obtained, Tukey adjustment was used for multiple
comparison purposes. Kruskal Wallis and Dunn’s test were
used to analyze data presented in Figures 1, 2D and 2E.
Statistical signiﬁcance was considered achieved when the
value of P <0.05. For the in vitro studies, we ran 3
independent experiments performed in duplicate for each
point.
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Figure 1. Mitochondrial Drp1 translocation in cardiac myocytes under ischemia-reoxygenation injury is blocked by P110. A, Primary culture
cardiomyocytes were subjected to 2 hour of ischemia followed by 2 to 60 minutes of reoxygenation. Western blot analysis of Drp1 in total and
mitochondrial fractions was determined by anti-Drp1 antibodies. VDAC was used as a loading control. Quantitation of the levels of Drp1 is
provided in a histogram. B, Cells were treated with peptide TAT47-57 and P110 (1 lmol/L) for 30 minutes prior 2 hours ischemia and during
30 minutes reoxygenation before analyzing Drp1 levels as above. P110 decreased Drp1 levels at the mitochondria. Enolase and VDAC were used
as a loading controls and subcellular compartment controls. C, Cross-linked proteins from total lysate cardiomyocytes after IRO treated with
control or P110 peptide were immunoprecipitated using anti-Fis1, anti-Mff and anti-MIEF1, respectively. Drp1 co-immunoprecipitated was
analyzed by Western blot analysis. Antibody control and 5% input is shown for respective proteins. The amounts of pulled-down Drp1 are shown
under the respective blots, normalized to the respective protein. Data are expressed as meanSE of three independent experiments performed in
duplicate for each group. (*P<0.05 vs normoxia, **P<0.05 vs IRO). Drp1 indicates dynamin related protein 1; Fis1, ﬁssion protein 1; IRO, ischemia
and reoxygenation; VDAC, voltage-dependent anion channel.
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Results
Translocation of Drp1 and Binding to Fis1 in
Cardiac Myocytes is Inhibited by P110 Peptide
Cytosolic Drp1 associates with the mitochondrial adaptor
protein, Fis1, to trigger Drp1 activation and further mitochon-
drial ﬁssion.26–28 We ﬁrst determined whether simulated
ischemia results in mitochondrial translocation and activation
of Drp1. We used the previously described protocol for heart
mitochondrial isolation21,29 and observed that 2 hours of
ischemia followed by IRO for 2 to 60 minutes resulted in Drp1
translocation to the mitochondria of rat neonatal cardiomyo-
cytes in culture. There was a 20010% increase in the amount
of mitochondrial Drp1 after 10 minutes of reoxygenation as
compared with cells left in normoxic conditions (Figure 1A,
middle and right panels). After 60 minutes of reperfusion,
mitochondrial levels of Drp1 returned to basal levels, while the
total cellular levels of Drp1 remained unchanged throughout the
treatment (Figure 1A, left). Treatment with the Drp1/Fis1
protein/protein interaction inhibitor, P110 (1 lmol/L),
30 minutes before ischemia and during ischemia and reperfu-
sion reduced IRO-induced increase of mitochondrial Drp1 by
503% (Figure 1B). P110 does not change mitochondrial Drp1
levels under normoxic condition relative to untreated cells
(0.230.02 versus 0.20.03, respectively).
A number of adaptor proteins bind mitochondrial Drp1.10–12
However, IRO increases Drp1 association only with Fis1 and
P110 selectively inhibited only this interaction, not affecting
the interaction of Drp1 with its other adaptor proteins, Mff or
MIEF1, in cardiomyocytes (Figure 1C). Therefore, P110 is a
selective inhibitor of Drp1 binding to Fis1.
IRO-induced Mitochondrial Fragmentation,
Cytochrome c Release and ROS Elevation are
Inhibited by P110 Treatment
We next determined mitochondrial fragmentation following
IRO in cultured rat cardiac myocytes. Less than 10% of the
cells have fragmented mitochondria under normoxic condi-
tions. Following IRO, 305% of the cells exhibited excessive
mitochondrial fragmentation (dot-like mitochondria), an effect
that was inhibited by 584% in the presence of P110
(Figure 2A). IRO-induced ﬁssion was associated with a 2-fold
increase in the release of mitochondrial cytochrome c to the
cytosolic fraction, indicating a loss of mitochondrial integ-
rity; this increase was blocked by treatment with P110
(Figure 2B). We determined apoptosis in cells subjected IRO
by measuring the number of Terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL)-positive cells.
IRO caused an increase of 673% of TUNEL-positive cells and
P110 treatment decreased TUNEL-positive cells by 382%
(Figure 2C). Note that P110 treatment did not affect the
number of TUNEL-positive cells under normoxic condition. IRO
also increased cellular and mitochondrial ROS production
(measured by CellRox and Mitosox, respectively) 708% and
417%, and these were reduced to basal levels following
P110 treatment (Figure 2D and 2E). These data demonstrated
that inhibition of Drp1 association with the mitochondria by
P110 greatly inhibited mitochondrial fragmentation and ROS
production and maintained mitochondrial integrity.
P110 Treatment Reduced Infarct Size and
Restored Mitochondrial Morphology and Function
in an Ex vivo Model of MI
We next examined mitochondrial fragmentation in rat heart
subjected to IR injury, using the Langendorff preparation30
(Figure 3A). Electron micrographs show well-organized mito-
chondria along the sarcomeres (Figure 3B, left panel). After
IR, the intersarcomeric mitochondria were smaller, and
treatment with P110 (1 lmol/L), as described in Figure 3A,
greatly restored mitochondrial morphology and organization
along the contractile elements in these hearts (Figure 3B right
versus middle panels); Figure 3C provides lower magniﬁcation
images, demonstrating the structural beneﬁts of P110
treatment at reperfusion.
To provide a better quantitation of mitochondrial fragmen-
tation by IR and the effect of the treatment with the Drp1
inhibitor P110, we determined mitochondrial size using
ﬂuorescence-activated cell sorting (FACS) analysis.24 After
IR, there was a 383% reduction in mitochondrial size relative
to mitochondria isolated from normoxic hearts, shown by the
reduced forward scatter of the mitochondria (Figure 3D).
Treatment with P110 at reperfusion resulted in normalization
of mitochondrial size; the distribution of size of mitochondria
isolated from normoxic heart and from hearts subjected to
ischemia that were treated with P110 at reperfusion was
almost indistinguishable (Figure 3D).
Using isolated mitochondrial fractions prepared from the
ex-vivo-model hearts, we next conﬁrmed that Drp1 associa-
tion with mitochondria increased following IR in this model.
There was a 2.20.1 fold increase in mitochondrial Drp1 after
90 minutes of reperfusion and P110 treatment blocked this
IR-induced increase in Drp1 association with the mitochondria
to 0.880.05-fold of basal (Figure 3E).
Two hours after IR, infarct size measured by triphenyl
tetrazolium chloride (TTC) staining was 605% of the tissue
and P110 treatment reduced the damage by about 30% (to
433% of the heart; Figure 4A). We reasoned that the
cardioprotective effect of this inhibitor may reﬂect its action
on a pathway related to improved mitochondrial function.
Indeed, treatment before and after reperfusion also reduced
IR-induced increases in H2O2 release from the mitochondria
(from 1605% in IR hearts treated with control peptide to
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1254% after treatment with P110; Figure 4B). ATP levels in
total heart tissue declined from 24.42.0 to 4.00.3 nmol/
mg tissue by IR. The Drp1 inhibitor P110, increased ATP levels
as compared to IR (from 4.00.3 to 6.80.3 nmol/mg
tissue, respectively; Figure 4C).
Autophagy and Apoptosis/cell Stress are Greatly
Reduced by the Drp1 Inhibitor, P110
In Figure 4D, we determined the level of apoptosis in hearts
subjected to IR by measuring the levels of caspase 3
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activation by proteolysis (measuring caspase 3 fragments
15 and 19 kDa). IR increased the levels of cleaved caspase
3 by 282% as compared with the levels in normoxic
hearts, indicating increased apoptosis under these experi-
mental conditions. P110 decreased the levels of cleaved
caspase 3 close to basal (normoxic) levels. Autophagy is
activated after excessive mitochondrial ﬁssion and loss of
mitochondrial membrane potential to remove damaged
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mitochondria.31–33 A marker of autophagy is the generation
of a lipidated LC3-II, a microtubule-associated protein 1
light chain 3, also known as ATG8.34 The levels in the
hearts of the autophagy marker, LC3-II increased 5-fold
(from 0.080.01 to 0.400.02) after IR in this ex vivo
model. Direct inhibition of either Drp1 at the onset of
reperfusion decreased this increase by 50% (to
0.250.02; Figure 4E). Similarly, the levels of the stress
marker, phosphorylated JNK35,36 decreased by 552% after
P110 treatment (Figure 4F).
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Acute and Chronic Effect of P110 Peptide Using
an In vivo MI Rat Heart Model
In the ﬁnal study, we measured the long-term beneﬁts of
acute inhibition of mitochondrial fragmentation. As depicted
in Figure 5A, after transient (30 minutes) LAD occlusion,
the indicated peptides were injected intraperitoneally and
cardiac functions were measured by echocardiogram. The
ejection fraction of control rats was 864% and MI reduced
it to 633% and 583% 3 days and 3 weeks after MI,
respectively (Table). MI rats also displayed reduced frac-
tional shortening (Figure 5B) and LV end-systolic diameter
compared to controls. P110 treatment did not affect these
values under control conditions. Rats treated with P110
peptide (a single intraperitoneal injection; 0.5 mg/kg) at
the onset of reperfusion showed improved cardiac function
as measured by ejection fraction and fractional shortening
3 days after the onset of reperfusion (to 372%) and this
was sustained when measured 3 weeks later (to 353%).
In addition to providing FS as a systolic index, Table
summarizes additional echocardiographic measurements,
including ejection fraction, to support our conclusion that
acute P110 treatment improved cardiac function. No
changes in cardiac structure were seen in MI rats (Table).
We next determined whether the acute treatment with
P110 after reperfusion resulted in long-term beneﬁt of
mitochondrial functions. Oxygen consumption was measured
in isolated mitochondria from hearts 3 weeks after myocar-
dial infarction. We found a clear disruption of mitochondrial
bioenergetics 3 weeks after MI, as depicted by reduced
oxygen consumption at state-3 (ADP-dependent state) and
upon carbonyl cyanide m-chlorophenyl hydrazone (CCCP)-
induced mitochondrial uncoupling (Figure 6A). There was also
a signiﬁcant decrease in the efﬁciency of mitochondrial
Table. Analysis of In vivo Cardiac Function by Echocardiography
Parameter
3 days 21 days
Norcon IRcon IRP110 IRcon IRP110
n=6 n=7 n=6 n=6 n=6
EF, % 864 633* 733*,‡ 583* 714*,‡
LVEdD, mm 6.60.2 6.80.3 6.60.4 7.40.3 6.70.5
LVEsD, mm 3.30.1 4.80.2* 4.20.3* 5.40.3* 4.30.3*,‡
dSEPth, mm 0.90.1 0.90.1 0.90.1 1.00.1 1.00.1
sSEPth, mm 1.60.2 1.30.2 1.50.2 1.60.1 1.60.1
dPWth, mm 1.00.1 1.10.1 1.10.1 1.20.1* 1.20.1
sPWth, mm 2.00.1 1.90.2 1.70.2 1.80.1 1.80.1
HR, bpm 32726 278.116 29615 27810 29012
dPWth, diastolic posterior wall thickness; dSEPth, diastolic septum thickness; EF, ejection fraction; HR, heart rate; IRcon, ischemia/reperfusion control; IRP110, ischemia/reperfusion treated
with P110 peptide; LVEdD, left ventricle end diastolic dimension; LVEsD, left ventricle end systolic dimension; n, at top of table, indicates the number of animals used for the
echocardiography study in the respective group; Norcon, normoxia (control); NorP110, Normoxia (treated with P110); sPWth, systolic posterior wall thickness; sSEPth, systolic septum
thickness.
*P<0.05 vs Norcon.
‡P<0.05 vs IRcon.
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oxidative phosphorylation, as measured by RCR (Figure 6B).
Acute treatment with P110 peptide only during the ﬁrst few
minutes of reperfusion resulted in preserved mitochondrial
function when measured 3 weeks after IR injury.
Reduction of oxygen consumption has been associated
with excessive mitochondrial ROS release in both acute and
chronic cardiac diseases.37,38 We therefore determined the
effect of acute P110 treatment on mitochondria ROS release
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as measured 3 weeks later. Three weeks after MI, hearts
displayed increased mitochondria H2O2 release at state-3,
state-4, and in the uncoupled state as compared to control
rats subjected to sham surgery 3 weeks earlier (Figure 6C).
Importantly, the presence of the Drp1 inhibitory peptide,
P110, during the ﬁrst few minutes of reperfusion decreased
H2O2 release from the mitochondria upon the addition of ADP
(state-3), oligomycin (state-4) and CCCP (uncoupled state),
demonstrating an improvement in mitochondria bioenergetics
(Figure 6C). P110 treatment did not affect either mitochon-
drial respiration or H2O2 release in control rats (Figure 6).
Taken together, our results show that 3 weeks after IR,
cardiac mitochondria have a prominent uncoupling between
the mitochondrial electron transport chain and oxidative
phosphorylation. Obviously, the half-life of the peptide is
short; however, such a P110 treatment was sufﬁcient to
reduce pathological cardiac remodeling and mitochondrial
dysfunction as a result of a smaller initial injury to the
myocardium that was subjected to IR.
Discussion
There is much interest in the role of mitochondrial dynamics
and functions in cardiovascular diseases.7,24 The majority of
the mitochondria in heart tissue are tightly packed between
the cardiac myoﬁbers, such that the fusion and ﬁssion
process may be restricted. Some reports show that decreased
mitochondrial ﬁssion prior to the ischemic event is cardio-
protective4,15 and that excessive ﬁssion and fragmentation
contribute to cell death in other cell types.31,39 Yet, ﬁssion,
especially under stress, is also thought to be required to
enable the elimination of dysfunctional mitochondria, thus
preserving the healthy population of mitochondria in a variety
of cell types and in the myocardium during heart failure, for
example.40
Here, we describe the beneﬁcial effects of an inhibitor of
excessive mitochondria ﬁssion and fragmentation, P110, in
cultured rat cardiomyocytes, an ex vivo model of cardiac
ischemia and an in vivo ratmodel ofmyocardial infarction. P110
inhibitory peptide is composed of a 7-amino-acid peptide
(DLLPRGT; Drp149-55), representing a homology sequence
between Drp1 and Fis1 (ELLPKGS; Fis160-66; the three homol-
ogous differences relative to Drp1 are provided in italics).18 The
Drp1-derived peptide was bound to the cell permeable peptide,
TAT47-57.
41 We previously showed that P110 inhibits excessive
activation of Drp1 by inhibiting its GTPase activity and the
interaction between Drp1 and Fis1 on the mitochondria under
stress conditions in neuronal cells and in a Parkinson’s disease
model.18 We also showed that P110 has no effect on any other
mitochondrial ﬁssion or fusion proteins or on other members of
the dynamin family (see also Figure 1) and that it does not
cause any effects in nonstress conditions.18 Therefore, P110
selectively inhibits pathological (excessive) mitochondrial
ﬁssion and fragmentation.
Mitochondrial fragmentation results in loss of ATP
synthesis and increased ROS production that lead to tissue
damage. Using an ex vivo Langendorff model and in vivo LAD
occlusion model, we found that treating with P110 both
before and after reperfusion inhibited reperfusion-induced
excessive ﬁssion, reduced H2O2 release, and increased ATP
production and O2 consumption in heart after IR. P110
decreased infarct size and improved cardiac function in an in
vivo MI model.
Previous work has shown that metabolically impaired
mitochondria are preferably targeted by autophagy and that
inhibition of ﬁssion reduces autophagy in a hepatocytemodel of
mitochondrial stress and in yeast.42,43 Similarly, we found that
P110 treatment of the heart before and after reperfusion
inhibits the increase in the autophagy marker, LC3-II, after IR as
well as the increase of cleaved caspase 3 and JNK phosphor-
ylation, markers of apoptosis and cell death, respectively.35,36
Finally, we demonstrated that the effect of P110 peptide,
administered only at the onset of reperfusion, inhibits the
excessive pathological fragmentation driven by Drp1 binding to
Fis1 that contributes further to ROS production and cell death,
thus improving cardiac and mitochondrial functions even when
measured 3 weeks afterMI. Since the half-life of these peptides
is likely less than one hour, these data demonstrate that acute
excessivemitochondrial ﬁssion results in long-term impairment
of the myocardium and that inhibiting this acute impairment
may reduce the subsequent deterioration of cardiac function
after myocardial infarction.
The effect of the pharmacological inhibitor of Drp1, mdivi-114
was previously determined in an in vivo MI model in mice15
and in rats.44 Mdivi-114 has an IC50 of 10 lmol/L14 and in
the in vivo studies that showed a reduction in infarct size
after MI, mdivi-1 was used at a dose that was equivalent to
50 lmol/L administered before MI.15 (10 lmol/L mdivi-1
was ineffective in reducing cardiac injury in the ex vivo and in
vivo models15). A recent report demonstrates that mdivi-1
also decreases the activity of delayed-rectiﬁer K+ current in
murine cardiac HL-1 cells, with the same IC50 value
(12 lmol/L).45 Further, in that study, mdivi-1 was shown
to prolong the duration of action potentials and increased
spontaneous action potentials in HL-1 cells. The observed
effects of mdivi-1 on K+ channels were direct (as evidenced,
for example, by patch-clamp experiments where the drug was
given through the pipette) and were not associated with
mdivi-1 inhibition of mitochondrial ﬁssion. It remains to be
determined whether the beneﬁt of mdivi-1 reported repre-
sents, in part, the suppressed K+ channels during MI, in vivo.
Mdivi-1 beneﬁts were determined only after 2 hours of
reperfusion15 and the long-term beneﬁts on cardiac mito-
chondrial functions and on cardiac functions were not
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determined. Further, the drug was administered prior to
ischemia. Here, we showed that acute inhibition of ﬁssion at
the onset of reperfusion is sufﬁcient to provide beneﬁts to
the myocardium as measured both within an hour of
treatment, but also after 3 weeks. Therefore, our study
shows that mitochondrial fragmentation is part of the
reperfusion injury.
Our study shows two previously unreported beneﬁts of
inhibiting mitochondrial fragmentation. First, we demon-
strated here that P110 treatment was sufﬁcient to restore
mitochondrial functions in three different heart models of IR
injury. Second, we showed that the mitochondrial fragmen-
tation is triggered by reperfusion, as an inhibitor of ﬁssion
given at reperfusion was sufﬁcient to restore cardiac tissue
integrity and cardiac functions. We conclude that controlling
Drp1-mediated excessive mitochondrial ﬁssion after MI, at the
onset of reperfusion, contributes to increased cardiac
protection and prevention of dysfunction.
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